1. Home
  2. KEN vs QURE Comparison

KEN vs QURE Comparison

Compare KEN & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kenon Holdings Ltd.

KEN

Kenon Holdings Ltd.

HOLD

Current Price

$64.65

Market Cap

3.5B

Sector

Utilities

ML Signal

HOLD

Logo uniQure N.V.

QURE

uniQure N.V.

HOLD

Current Price

$24.79

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KEN
QURE
Founded
2014
1998
Country
Singapore
Netherlands
Employees
N/A
248
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.1B
IPO Year
2014
2013

Fundamental Metrics

Financial Performance
Metric
KEN
QURE
Price
$64.65
$24.79
Analyst Decision
Buy
Analyst Count
0
14
Target Price
N/A
★ $45.00
AVG Volume (30 Days)
9.1K
★ 1.2M
Earning Date
05-27-2026
05-05-2026
Dividend Yield
★ 4.39%
N/A
EPS Growth
N/A
★ 29.67
EPS
★ N/A
N/A
Revenue
N/A
★ $13,107,000.00
Revenue This Year
N/A
$126.12
Revenue Next Year
N/A
$200.43
P/E Ratio
$9.21
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$44.30
$8.73
52 Week High
$95.93
$71.50

Technical Indicators

Market Signals
Indicator
KEN
QURE
Relative Strength Index (RSI) 48.14 17.32
Support Level $63.84 $21.91
Resistance Level $70.27 $27.34
Average True Range (ATR) 1.07 2.15
MACD -0.06 -1.67
Stochastic Oscillator 62.80 7.07

Price Performance

Historical Comparison
KEN
QURE

About KEN Kenon Holdings Ltd.

Kenon Holdings Ltd is a holding company that operates dynamic, growth-oriented businesses. The company's operating segments include: OPC Power Plants, which generates and supplies electricity and energy in Israel; and CPV Group, which generates and supplies electricity and energy in the United States. It generates maximum revenue from the OPC Power Plants segment, which generates and supplies electricity and energy in Israel. CPV Group is a limited partnership owned by OPC, which generates and supplies electricity and energy in the United States. Geographically, the company generates a majority of its revenue from Israel and the rest from the United States.

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.

Share on Social Networks: